InsidersTradesSigma
Follow the SCL사이언스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, SCL사이언스 has published 3 insider filings. Market capitalisation: €55.8bn. The latest transaction was disclosed on 18 March 2026 (Other). Among the most active insiders: SCL사이언스. The full history is openly available.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 27,130 of 28,896 companies
17.3
score / 100
Value18
Quality17
FCF yld-8.3%
Earn yld-7.1%
EV/EBITDA·
ROE-13%
Gross mgn19%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 March 2026
About SCL사이언스
SCL사이언스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.